AdvisorShares Psychedelics ETF—— (—)Compass Pathways—— (—)Definium Therapeutics—— (—)GH Research—— (—)Helus Pharma—— (—)MIRA Pharmaceuticals—— (—)Neuphoria Therapeutics—— (—)Eli Lilly—— (—)Johnson & Johnson—— (—)AbbVie—— (—)Otsuka Pharmaceutical—— (—)Numinus Wellness—— (—)Optimi Health—— (—)PharmAla Biotech—— (—)Enveric Biosciences—— (—)Incannex Healthcare—— (—)Aurora Cannabis—— (—)Cronos Group—— (—)SNDL—— (—)Bright Minds Biosciences—— (—)PharmaTher Holdings—— (—)IM Cannabis—— (—)MariMed—— (—)Vireo Growth—— (—)

Loading prices

Policy Tracker · City

Washington, DC

Still illegal, but personal use brings a fine or no penalty instead of a crime.

Current status

Decriminalized

Voters made noncommercial adult entheogenic plant and fungus activity among the Metropolitan Police Department's lowest enforcement priorities and asked prosecutors to stop related prosecutions. State and federal law still apply.

State and federal law still apply.

Law & key sections

Initiative 81 — Entheogenic Plant and Fungus Policy Act of 2020 (D.C. Law 23-268)

code.dccouncil.gov

Official page

Open the full official document

Key sections

Key sections for this law haven't been quoted yet. Open the full document to read it.

Bills

No reviewed bills on record.

Timeline of laws

Loading timeline…

Embed this

PlaceSubstanceTheme

Embed code

<iframe src="https://psychedelicamericas.org/embed/tracker/USA-DC-WASHINGTON?substance=psilocybin&theme=light" title="Policy Tracker — Psychedelic State(s) of America" width="100%" height="230" style="border:0;max-width:480px" loading="lazy"></iframe>

Sources

Initiative 81 — Entheogenic Plant and Fungus Policy Act of 2020 (D.C. Law 23-268) · code.dccouncil.gov How this status was decided